Progyny PGNY Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $131.61M+20.5% | $112.24M-30.9% | $133.98M+46.5% | $132.51M+39.5% | $109.24M-5.0% | ||
| $93.5M-36.3% | $197.86M+201% | $211.23M+46.4% | $172.59M+3.2% | $146.88M-42.8% | ||
| $1.01B-9.1% | $1.04B-5.7% | $1.06B-4.9% | $1.09B-1.3% | $1.11B+3.4% | ||
| $501.55M-11.7% | $551.78M+16.7% | $622.01M+13.9% | $594.4M+2.1% | $567.69M-16.7% | ||
| $35.71M+127% | $29.93M+142% | $24.74M+107% | $19.94M+87.5% | $15.74M+53.8% | ||
| $19.88M+1.2% | $19.98M+28.6% | $19.96M+26.4% | $19.96M+27.9% | $19.65M+65.4% | ||
| $5.97M-11.6% | $6.22M— | $6.43M— | $6.64M— | $6.75M— | ||
| $698.34M-4.4% | $742.44M+22.3% | $795.23M+20.5% | $760.95M+8.9% | $730.29M-8.1% | ||
| $545.5M+4.3% | $533.39M+5.1% | $504.42M-6.2% | $511.79M-5.1% | $523.02M+1.0% | ||
| $235.74M-0.6% | $202.39M+20.0% | $210.49M+1.0% | $220.42M-2.2% | $237.13M+15.2% | ||
| $258.99M-1.6% | $226.39M+22.3% | $235.22M+4.5% | $245.93M+1.4% | $263.13M+18.2% | ||
| $9K0.0% | $9K0.0% | $9K-100.0% | $9K-100.0% | $9K-100.0% | ||
| $227.06M+42.5% | $202.83M+40.6% | $190.34M+42.3% | $176.48M+43.1% | $159.37M+49.1% | ||
| $439.34M-6.0% | $516.04M+22.3% | $560M+28.8% | $515.02M+12.9% | $467.16M-18.3% | ||
| $698.34M-4.4% | $742.44M+22.3% | $795.23M+20.5% | $760.95M+8.9% | $730.29M-8.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Progyny cover its short-term obligations?
- Its current ratio is 2.13 — current assets exceed current liabilities.
- Where does Progyny's balance sheet data come from?
- Every line is extracted from Progyny's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.